What is Schimke Immuno-Osseous Dysplasia

Schimke immuno-osseous dysplasia (SIOD) is a rare, multisystem genetic disorder characterized by short-stature skeletal dysplasia, progressive renal failure, and immune system deficiency. It is caused by mutations in the SMARCAL1 gene and requires coordinated care from a multidisciplinary medical team to manage its complex, systemic effects.

What are the primary systems affected by Schimke immuno-osseous dysplasia?

Schimke immuno-osseous dysplasia impacts several organ systems, primarily the skeletal, renal, and immune systems. Individuals often experience spondyloepiphyseal dysplasia, which leads to disproportionate short stature. Renal involvement is a hallmark of the condition, frequently manifesting as focal segmental glomerulosclerosis that can progress to end-stage renal disease. Immune dysfunction is also common, often involving T-cell deficiency, which increases susceptibility to infections.

How common is Schimke immuno-osseous dysplasia?

Schimke immuno-osseous dysplasia is an extremely rare condition with an estimated prevalence of less than 1 in 1,000,000 individuals worldwide. While 4 members of the DiseaseMaps.org community are currently living with this diagnosis, the total number of documented cases globally remains very low. The disease typically presents in early childhood, though the age of onset and the severity of symptoms can vary significantly between individuals.

What causes Schimke immuno-osseous dysplasia?

The condition is inherited in an autosomal recessive pattern, meaning an individual must inherit two copies of a mutated SMARCAL1 gene—one from each parent—to develop the disease. The SMARCAL1 gene provides instructions for producing a protein involved in DNA repair and chromatin remodeling. When this protein is dysfunctional, the body’s cells struggle to maintain DNA stability, which contributes to the multisystem features seen in Schimke immuno-osseous dysplasia.

Key clinical features and differentiators

Clinicians often distinguish Schimke immuno-osseous dysplasia from other skeletal dysplasias by identifying the specific combination of symptoms. Key diagnostic markers include:

• Profound short stature (often falling below the third percentile).


• Early-onset proteinuria or hypertension indicating kidney involvement.


• Characteristic facial features, such as a thin face and prominent forehead.


• Cerebral ischemia or "stroke-like" episodes in some individuals.


• Immune system testing showing low T-cell counts.

Next steps

• Consult with a clinical geneticist to confirm the diagnosis through SMARCAL1 molecular testing.


• Coordinate care with a pediatric nephrologist and immunologist to monitor organ function.


• Connect with the DiseaseMaps.org community to share experiences with other families affected by Schimke immuno-osseous dysplasia.


• Discuss potential clinical trial participation or research registries with your specialist.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Schimke immuno-osseous dysplasia


• Orphanet: Schimke immuno-osseous dysplasia (ORPHA:3145)


• Online Mendelian Inheritance in Man (OMIM): #242900 (SMARCAL1-related disorders)


• National Center for Biotechnology Information (NCBI) GeneReviews: SMARCAL1-Related Disorders